The company received this award after the successful completion of the Phase I contract, which studied BLZ-100 in canine patients with multiple tumor types. The award will fund
Poorly soluble drug candidates are difficult to administer even as intravenous drugs. Low concentrations may limit therapeutic response and require long infusion periods which are poorly tolerated and
Teva expects to complete the NDA submission by the end of 2014. CEP-33237 is an investigational, 12-hour, acetaminophen-free, formulation of extended-release (ER) hydrocodone for the management of pain
As patients find that they are unable to refill their hydrocodone prescription, this paper presents alternatives that should be discussed with their physician. The release of the white
Concomitant with this news, DBM, Inc. was also approved to proceed with the Phase 2 portion of a Fast Track SBIR-funded program funded by the NIH to develop
Mary’s Healing Heart has a significantly higher Cannabidiol (CBD) level and lower THC level than the most well known high-CBD strains available today. A recent media blitz has
Every October, CADCA urges its membership to plan and promote an educational event – such as town hall meetings for parents, youth, and local advocates – to educate
"The microbiome is an important area of medical research for Mayo Clinic, and this collaboration represents a broad and significant effort in our attempt to develop therapeutics targeting
Achieve Nutrition Systems CEO Amanda Halliday said, "Partnering with Game Plan was the perfect fit for Achieve Nutrition Systems. We are always on the look-out for new revenue
ARIAD will receive $50 million in exchange for a fully paid up license to this technology and return of its equity stake in closely held Bellicum. The scope
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.